Business Standard

WHO seeks more info from Bharat Biotech for emergency listing of Covaxin

The documents showed Bharat Biotech submitted Expression of Interest with the WHO for emergency use listing (EUL) on April 19

Bharat Biotech, Covaxin
Premium

Photo: Shutterstock

BS Web Team New Delhi
The World Health Organization (WHO) has sought more information from Bharat Biotech on its emergency use listing (EUL) application for Covaxin, according to the documents on the global health agency's website.

The documents showed Bharat Biotech submitted Expression of Interest with the WHO for EUL on April 19.

Bharat Biotech will hold a pre-submission meeting with WHO in May or June. After the meeting, there are further three stages where the application will be reviewed before the approval.

The WHO’s EUL opens the door for countries to expedite their own regulatory approval processes to import and administer the vaccine. It also enables UNICEF

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 24 2021 | 5:41 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com